These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2482710)

  • 41. Prostacyclin and molsidomine synergise in their fibrinolytic and anti-platelet actions in patients with peripheral arterial disease.
    Bieroń K; Grodzińska L; Kostka-Trabka E; Gryglewski RJ
    Wien Klin Wochenschr; 1993; 105(1):7-11. PubMed ID: 8438599
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of the vasodepressor action of ZK 36 374, a stable prostacyclin derivative, PGI2 and PGE1 with their effect on platelet aggregation and bleeding time in rats.
    Casals-Stenzel J; Buse M; Losert W
    Prostaglandins Leukot Med; 1983 Feb; 10(2):197-212. PubMed ID: 6189133
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of a stable prostacyclin analogue on platelet activity and on host immunocompetence in mice.
    Costantini V; Fuschiotti P; Giampietri A; Allegrucci M; Agnelli G; Nenci GG; Fioretti MC
    Prostaglandins; 1990 Jun; 39(6):581-99. PubMed ID: 1695382
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-platelet and anti-thrombotic effects of OP-41483.alpha-CD, a prostacyclin analogue, in experimental animals.
    Katsube N; Sakaguchi K; Fujitani B; Aishita H
    Prostaglandins Leukot Essent Fatty Acids; 1993 Oct; 49(4):795-804. PubMed ID: 8259376
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of platelet aggregation and antagonism of vasopressin-induced ECG changes in primates by a carboprostacyclin analogue, ZK 36374.
    Adaikan PG; Karim SM; Lau LC; Tai MY; Kottegoda SR
    Thromb Res; 1984 Feb; 33(3):333-40. PubMed ID: 6200948
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vivo measurement of the disaggregatory action of prostacyclin. A methodological study.
    Hermán F; Hadházy P; Magyar K
    Thromb Res; 1986 Dec; 44(5):575-85. PubMed ID: 3544328
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synergistic platelet antiaggregatory effects of the adenylate cyclase activator iloprost and the guanylate cyclase activating agent SIN-1 in vivo.
    Spiecker M; Darius H; Meyer J
    Thromb Res; 1993 Jun; 70(5):405-15. PubMed ID: 7690993
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of Iloprost (ZK 36 374), a novel prostacyclin analogue, on ADP-induced platelet aggregation.
    Wadenvik H; Kutti J
    Acta Haematol; 1985; 73(4):224-7. PubMed ID: 2414956
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute reversible reduction of PGI2 platelet receptors after iloprost infusion in man.
    Modesti PA; Fortini A; Poggesi L; Boddi M; Abbate R; Gensini GF
    Thromb Res; 1987 Dec; 48(6):663-9. PubMed ID: 2448896
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nonprostanoid prostacyclin mimetics. 5. Structure-activity relationships associated with [3-[4-(4,5-diphenyl-2-oxazolyl)-5- oxazolyl]phenoxy]acetic acid.
    Meanwell NA; Romine JL; Rosenfeld MJ; Martin SW; Trehan AK; Wright JJ; Malley MF; Gougoutas JZ; Brassard CL; Buchanan JO
    J Med Chem; 1993 Nov; 36(24):3884-903. PubMed ID: 7504734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nonprostanoid prostacyclin mimetics. 4. Derivatives of 2-[3-[2-(4,5-diphenyl-2-oxazolyl)ethyl]phenoxy]acetic acid substituted alpha to the oxazole ring.
    Meanwell NA; Rosenfeld MJ; Wright JJ; Brassard CL; Buchanan JO; Federici ME; Fleming JS; Gamberdella M; Hartl KS; Zavoico GB
    J Med Chem; 1993 Nov; 36(24):3871-83. PubMed ID: 8254619
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The orally active thia-imino-prostacyclin Hoe 892: antiaggregatory and cardiovascular activities.
    Schölkens BA; Gehring D; Jung W
    Prostaglandins Leukot Med; 1983 Mar; 10(3):231-56. PubMed ID: 6405394
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The antiplatelet and cardiovascular actions of a new carbacyclin derivative (ZK 36 374)--equipotent to PGI2 in vitro.
    Schrör K; Darius H; Matzky R; Ohlendorf R
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Jun; 316(3):252-5. PubMed ID: 6166877
    [No Abstract]   [Full Text] [Related]  

  • 54. Heparin-mediated neutralization of platelet antiaggregatory activity of prostacyclin (PGI2): studies on mechanism.
    Saba SR; Saba HI
    Am J Hematol; 1985 Oct; 20(2):97-105. PubMed ID: 3898823
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The cardiovascular and platelet effects of epoprostenol (prostacyclin, PGI2) are unaffected by beta-adrenoceptor blockade in man.
    Hassan S; Pickles H; Fish A; Burke C; Warrington S; O'Grady J
    Br J Clin Pharmacol; 1982 Sep; 14(3):369-77. PubMed ID: 6127095
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interactions of iloprost and sodium nitroprusside on vascular smooth muscle and platelet aggregation.
    Lidbury PS; Antunes E; de Nucci G; Vane JR
    Br J Pharmacol; 1989 Dec; 98(4):1275-80. PubMed ID: 2482103
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of adenosine diphosphate-induced intravascular aggregation of rat platelets in vivo by 6-oxo-prostaglandin E1.
    Oyekan AO; Botting JH
    Prostaglandins; 1987 Sep; 34(3):359-66. PubMed ID: 3324168
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of iloprost (ZK 36374), a prostacyclin derivative, on platelet function after ischaemic exercise in patients with stable angina pectoris.
    Grauso F; Biagi G; Puddu P; Bugiardini R; Capelli M; Coccheri S
    Thromb Res; 1987 Oct; 48(2):131-43. PubMed ID: 2447664
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vasodilation and inhibition of platelet aggregation by prostacyclins with modified omega-side chain.
    Schölkens BA; Bartmann W; Beck G; Lerch U; Konz E; Weithmann U
    Prostaglandins Med; 1979 Jul; 3(1):7-22. PubMed ID: 399529
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of intravenous ZK36-374, a stable prostacyclin analogue, on normal volunteers.
    Belch JJ; Greer I; McLaren M; Saniabadi AR; Miller S; Sturrock RD; Forbes CD
    Prostaglandins; 1984 Jul; 28(1):67-77. PubMed ID: 6207561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.